Log In
Print this Print this

BAY 1179470

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionKeratinocyte growth factor (KGF) receptor (KGFR; FGFR2; CD332) antibody
Molecular Target Keratinocyte growth factor (KGF) receptor (KGFR) (FGFR2) (CD332)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today